Phase I trial to evaluate the tumor and normal tissue uptake, radiation dosimetry and safety of (111)In-DTPA-human epidermal growth factor in patients with metastatic EGFR-positive breast cancer.

Autor: Vallis KA; Gray Institute for Radiation Oncology and Biology, University of Oxford Oxford, UK., Reilly RM; Leslie Dan Faculty of Pharmacy, University of Toronto Toronto, Canada ; Toronto General Hospital Research Institute Toronto, Canada ; Medical Imaging, University of Toronto Toronto, Canada., Scollard D; Leslie Dan Faculty of Pharmacy, University of Toronto Toronto, Canada., Merante P; Radiation Medicine Program, Princess Margaret Hospital, University of Toronto Canada., Brade A; Radiation Medicine Program, Princess Margaret Hospital, University of Toronto Canada., Velauthapillai S; Leslie Dan Faculty of Pharmacy, University of Toronto Toronto, Canada., Caldwell C; Medical Imaging, University of Toronto Toronto, Canada ; Medical Physics, Sunnybrook Health Sciences Center Toronto, Canada., Chan I; Medical Imaging, University of Toronto Toronto, Canada., Freeman M; Medical Imaging, University of Toronto Toronto, Canada., Lockwood G; Biostatistics, Princess Margaret Hospital Toronto, Canada., Miller NA; Pathology, University Health Network Toronto, Canada., Cornelissen B; Gray Institute for Radiation Oncology and Biology, University of Oxford Oxford, UK., Petronis J; Medical Oncology and Hematology, Princess Margaret Hospital Toronto, Canada., Sabate K; Biostatistics, Princess Margaret Hospital Toronto, Canada.

Publikováno v: American journal of nuclear medicine and molecular imaging [Am J Nucl Med Mol Imaging] 2014 Mar 20; Vol. 4 (2), pp. 181-92. Date of Electronic Publication: 2014 Mar 20 (Print Publication: 2014).

Synthesis and optical properties of phosphorus doped ZnO: X-ray absorption, X-ray emission, and X-ray excited optical luminescence studies.

Autor: Dong, Zhi Liang¹ (AUTHOR), Wang, Zhiqiang¹ (AUTHOR) zwang443@uwo.ca, Yiu, Yun-Mui¹ (AUTHOR), Fu, Jiamin¹ (AUTHOR), Lin, Bi-Hsuan² (AUTHOR), Chang, Lo-Yueh² (AUTHOR), Sham, Tsun-Kong¹ (AUTHOR) tsham@uwo.ca

Publikováno v: Pure & Applied Chemistry. Jun2023, Vol. 95 Issue 6, p643-653. 11p.

Formulation of a kit under Good Manufacturing Practices (GMP) for preparing [¹¹¹In]In-BnDTPA-trastuzumab-NLS injection: a theranostic agent for imaging and Meitner-Auger Electron (MAE) radioimmunotherapy of HER2-positive breast cancer.

Autor: Chan, Conrad¹ (AUTHOR), Prozzo, Vanessa¹ (AUTHOR), Aghevlian, Sadaf¹ (AUTHOR), Reilly, Raymond M.^1,2,3,4 (AUTHOR) raymond.reilly@utoronto.ca

Publikováno v: EJNMMI Radiopharmacy & Chemistry. 12/21/2022, Vol. 7 Issue 1, p1-21. 21p.

Radionuclides for Targeted Therapy: Physical Properties.

Autor: Stokke, Caroline^1,2 (AUTHOR) carsto@ous-hf.no, Kvassheim, Monika^1,3 (AUTHOR), Blakkisrud, Johan¹ (AUTHOR)

Publikováno v: Molecules. Sep2022, Vol. 27 Issue 17, p5429. 20p.

Mapping the Progress in Natural Dye‐Sensitized Solar Cells: Materials, Parameters and Durability.

Autor: Alim, Md. Abdul¹ (AUTHOR), Repon, Md. Reazuddin^2,3 (AUTHOR) reazmbstu.te@gmail.com, Islam, Tarikul^2,4 (AUTHOR), Mishfa, Kaniz Fatima¹ (AUTHOR), Jalil, Mohammad Abdul¹ (AUTHOR), Aljabri, Mahmood D.⁵ (AUTHOR) mdjabri@uqu.edu.sa, Rahman, Mohammed M.⁶ (AUTHOR) mmrahman@kau.edu.sa

Publikováno v: ChemistrySelect. 6/20/2022, Vol. 7 Issue 23, p1-23. 23p.